SCHEMBL24656168

SCHEMBL24656168

Cc1nn2ccccc2c1C(C)(C)C

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.41
MAPT P10636 2/20 0.41
PDE5A O76074 4/20 0.36
PDE4B Q07343 3/20 0.36
MEN1 O00255 2/20 0.36
MIF P14174 2/20 0.36
KMT2A Q03164 2/20 0.36
PDE3A Q14432 2/20 0.36
ADORA2A P29274 2/20 0.36
ADORA1 P30542 2/20 0.36
CYP1A2 P05177 1/20 0.36
CYP3A4 P08684 1/20 0.36
CYP2D6 P10635 1/20 0.36
CYP2C9 P11712 1/20 0.36
TSHR P16473 1/20 0.36
PDE4A P27815 1/20 0.36
CYP2C19 P33261 1/20 0.36
BLM P54132 1/20 0.36
PDE4C Q08493 1/20 0.36
PDE4D Q08499 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12997416 0.81 ALDH1A1 (0.38) ALDH1A1MAPTPDE5APDE4BMEN1
SCHEMBL20989735 0.80 EGFR (0.45) ALDH1A1MAPTPDE5APDE4BMEN1
SCHEMBL22792400 0.77 PDE4B (0.54) ALDH1A1MAPTPDE5APDE4BMEN1
SCHEMBL26029443 0.77 ALDH1A1 (0.36) ALDH1A1MAPTPDE5APDE4BMEN1
SCHEMBL24415150 0.77 HDAC1 (0.38) ALDH1A1MAPTPDE5APDE4BMEN1
SCHEMBL6490727 0.76 PDE5A (0.44) ALDH1A1PDE5APDE4BMEN1MIF
SCHEMBL25527213 0.75 MAPK9 (0.44) ALDH1A1MAPTPDE4BPDE3ACYP1A2
SCHEMBL6494096 0.74 ALDH1A1 (0.38) ALDH1A1MAPTPDE5APDE4BMEN1
SCHEMBL13646858 0.74 MIF (0.40) ALDH1A1MAPTPDE5APDE4BMEN1
SCHEMBL13257675 0.73 PDE5A (0.38) ALDH1A1PDE5APDE4BMEN1MIF

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11820766-B2 Monoacylglycerol lipase modulators JANSSEN PHARMACEUTICA NV (BE) 2023-11-21 US disclosed
US-11820766-B2 Monoacylglycerol lipase modulators JANSSEN PHARMACEUTICA NV (BE) 2023-11-21 US disclosed
US-20230242531-A1 Monoacylglycerol Lipase Modulators JANSSEN PHARMACEUTICA NV (BE) 2023-08-03 US disclosed
US-20230242531-A1 Monoacylglycerol Lipase Modulators JANSSEN PHARMACEUTICA NV (BE) 2023-08-03 US disclosed
US-20230145249-A1 Monoacylglycerol Lipase Modulators JANSSEN PHARMACEUTICA NV (BE) 2023-05-11 US disclosed
US-20220332713-A1 Monoacylglycerol Lipase Modulators JANSSEN PHARMACEUTICA NV (BE) 2022-10-20 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220332713-A1 Monoacylglycerol Lipase Modulators MGLL, LPL, PNLIP ALDH1A1 312/4885MAPT 2516/4885PDE5A 754/4885
US-20230242531-A1 Monoacylglycerol Lipase Modulators MGLL, LPL, PNLIP ALDH1A1 344/4885MAPT 2188/4885PDE5A 876/4885
US-20230145249-A1 Monoacylglycerol Lipase Modulators MGLL, LPL, PNLIP ALDH1A1 312/4885MAPT 2516/4885PDE5A 754/4885
US-11820766-B2 Monoacylglycerol lipase modulators MGLL, LPL, PNLIP ALDH1A1 312/4885MAPT 2516/4885PDE5A 754/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.